Device Trial Radar · NCT07851402
Pediatric/Adolescent WatchPAT 400 Reliability Pilot Study
Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
35
Planned (sponsor's estimate)
Start
Dec 1, 2026
Primary completion
Nov 30, 2027
Study completion Dec 1, 2028
Sponsor
- Lead sponsor
- Milton S. Hershey Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 1, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 6 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn whether a newer sleep-testing device gives results that closely match the standard overnight sleep study, in children and adolescents ages 6-18 who are being evaluated for possible sleep apnea. The main questions it aims to answer are: Does the new device (WatchPAT 400) give breathing and oxygen level results that agree with the standard overnight sleep study (polysomnography)? How reliably can two doctors, each looking at only one test's results, arrive at similar conclusions about a child's sleep apnea? Participants will: Have their regular, already-scheduled overnight sleep study performed exactly as usual Wear the WatchPAT 400 device (a small sensor on one finger, a wrist unit, and one adhesive patch on the chest) at the same time, during that same night Have both sets of results reviewed separately by two different study doctors Researchers will compare the results from the WatchPAT 400 device to the results from the standard sleep study to see how closely they agree, and how well the new device performs at detecting sleep apnea in children and teenagers.
Conditions
- Pediatric Sleep Disordered Breathing
- Obstructive Sleep Apnea
Interventions
WatchPAT 400Device
A peripheral arterial tonometry (PAT)-based home sleep apnea testing device (Itamar Medical/ZOLL Itamar; FDA 510(k) K250460) consisting of a finger probe, wrist-worn recording unit, and adhesive chest sensor patch. The device is worn overnight, simultaneously with standard polysomnography, to generate an apnea-hypopnea index, respiratory disturbance index, sleep-stage estimates, and, in this device generation, a central apnea index and hypoxic burden measure, for comparison against polysomnography results.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Agreement Between WatchPAT 400-Derived Apnea-Hypopnea Index (pAHI) and Polysomnography-Derived Apnea-Hypopnea Index (AHI)Time frame: Single overnight recording (one night)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Penn State Hershey Medical Center
Hummelstown, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.